Article
Patient-Reported Outcomes of Azelaic Acid Foam 15% for Patients With Papulopustular Rosacea: Secondary Efficacy Results From a Randomized, Controlled, Double-blind, Phase 3 Trial
- Author:
- Stephen Tyring, MD, PhD
- James A. Solomon, MD, PhD
- Gerald Staedtler, MSc
- Jason P. Lott, MD, MSHP, MHS
- Richard Nkulikiyinka, MD
- Kaweh Shakery, MD
Patient-reported treatment outcomes are important for evaluating the impact of drug therapies on patient experience. A randomized, double-blind,...